Phase 1 Trial Demonstrates Safety, Tolerability of Autologou

Results showed autologous FMT was safe and well-tolerated but did not affect time to normalized intestinal habits compared to placebo.

Related Keywords

Stockholm , Sweden , Danderyd , Johan Ursing , Centers For Disease , Karolinska Institute , Department Of Infectious Diseases At Danderyd Hospital , Karolinska Trial Alliance , Karolinska Institute Johan Ursing , Infectious Diseases , Danderyd Hospital , Disease Control , Clostridium Difficile , Accessed October , Ccdi , C Diff , Clostridioides Difficile Infection , Fecal Microbiota Transplantation , Cfmt , Tautologous , Phase 1 , Trial , Safety , Tolerability ,